ERNA — ERNEXA THERAPEUTICS INC
As of Q2 2026, 2 SEC-registered investment managers reported holding ERNA (ERNEXA THERAPEUTICS INC) in their latest 13F filings, with a combined reported value of $100.66K across 15.14K shares. That is -95.2% by share count (-301.07K shares) versus the previous quarter, while reported value moved +60.0%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 2 trimmed, 3 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
ERNA is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Citadel Advisors history | Q2 2026 | 15.10K | $100.44K | 0.00% | Reduce |
| Geode Capital Management history | Q1 2026 | 244.45K | $48.64K | 0.00% | Add |
| Vanguard Group history | Q4 2025 | 35.92K | $43.11K | 0.00% | Add |
| Citigroup Inc history | Q1 2025 | 153.16K | $27.26K | 0.00% | Add |
| Millennium Management history | Q4 2024 | 45.05K | $13.24K | 0.00% | New |
| UBS Group AG history | Q1 2026 | 21.23K | $4.22K | 0.00% | Add |
| Goldman Sachs Group history | Q1 2026 | 16.63K | $3.31K | 0.00% | New |
| BlackRock Inc history | Q2 2026 | 33 | $219 | 0.00% | Reduce |
| Wells Fargo & Co history | Q1 2024 | 28 | $67 | 0.00% | Hold |
| Bank of America Corp history | Q4 2025 | 34 | $41 | 0.00% | Add |
| Morgan Stanley history | Q4 2025 | 30 | $36 | 0.00% | Reduce |
| Renaissance Technologies history | Q1 2024 | 10.08K | $24 | 0.00% | New |
| JPMorgan Chase & Co history | Q1 2025 | 53 | $9 | 0.00% | Reduce |
| Fidelity Management & Research (FMR) history | Q1 2025 | 2 | $0 | — | New |
New Positions (Q2 2026)
No fund opened a new position this quarter.
Fully Exited (vs previous quarter)
- Geode Capital Management sold 244.45K sh · $48.64K
- UBS Group AG sold 21.23K sh · $4.22K
- Goldman Sachs Group sold 16.63K sh · $3.31K
Fund Position History — shares by quarter (top 14 funds)
| Fund | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Citadel Advisors | — | — | — | — | — | 10.09K | — | — | — | 65.57K | — | — | — | 33.08K | 15.10K |
| BlackRock Inc | — | — | — | — | — | — | — | 14.92K | 14.92K | 12.30K | 820 | 820 | 820 | 820 | 33 |
| Morgan Stanley | 1.36K | 50 | 50 | 50 | 50 | 50 | 50 | 50 | — | — | 554 | 77 | 30 | — | — |
| Goldman Sachs Group | — | — | 11.28K | — | — | — | — | — | 12.81K | 18.05K | — | — | — | 16.63K | — |
| Bank of America Corp | 9 | 9 | — | — | — | — | 29 | 123 | 295 | 309 | 21 | 33 | 34 | — | — |
| Geode Capital Management | 13.98K | 13.98K | 13.69K | 22.49K | 22.49K | 22.49K | 23.72K | 20.43K | 257.31K | 293.15K | 20.07K | 20.45K | 23.62K | 244.45K | — |
| UBS Group AG | — | 3.86K | — | 105 | — | 741 | — | 83.62K | 16.86K | 12.47K | 548 | — | 600 | 21.23K | — |
| Vanguard Group | 29.07K | 19.07K | 19.07K | 24.90K | 26.10K | 26.10K | 26.10K | 26.10K | 26.10K | 38.19K | — | 11.15K | 35.92K | — | — |
| Fidelity Management & Research (FMR) | 1 | 1 | 1 | 1 | 1 | — | — | — | — | 2 | — | — | — | — | — |
| JPMorgan Chase & Co | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 59 | 53 | — | — | — | — | — |
| Renaissance Technologies | 17.54K | 13.05K | — | — | — | 10.08K | — | — | — | — | — | — | — | — | — |
| Citigroup Inc | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 153.16K | — | — | — | — | — |
| Millennium Management | — | — | — | — | — | — | — | — | 45.05K | — | — | — | — | — | — |
| Wells Fargo & Co | 26 | 16 | 33 | 26 | 28 | 28 | — | — | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details